Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 04, 2015 3:47 AM ET

Capital Markets

Company Overview of Sanofi-Genzyme BioVentures

Company Overview

Sanofi-Genzyme BioVentures is a venture capital arm of Genzyme Corp. specializing in investments in growth capital. It only invests in early-stage life science companies. The firm prefers to invest in private biotech and healthcare companies; including rare diseases, oncology, vaccines, integrated health solutions and therapies. It prefers to invest globally with a focus on North America and Europe. The firm typically invests less than or equal to $5 million in a single round of financing and a maximum of $10 million in a single portfolio company for an equity ownership of less than 20 percent. It prefers to have an advisory committee membership, board observer or director positions or SAB m...

Genzyme Center

500 Kendall Street

Cambridge, MA 02142

United States

Founded in 2001

Phone:

617-252-7500

Fax:

617-252-7600

Key Executives for Sanofi-Genzyme BioVentures

Vice President and Managing Director
Director
Senior Director of Investments
Director of Investments
Compensation as of Fiscal Year 2015.

Sanofi-Genzyme BioVentures Key Developments

Sanofi-Genzyme BioVentures Presents at BIO-Europe Spring 2015, Mar-09-2015 04:00 PM

Sanofi-Genzyme BioVentures Presents at BIO-Europe Spring 2015, Mar-09-2015 04:00 PM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France. Speakers: Bernard Davitian, Vice President and Managing Director.

Sanofi-Genzyme BioVentures Presents at BIO-Europe 2014, Nov-03-2014 09:00 AM

Sanofi-Genzyme BioVentures Presents at BIO-Europe 2014, Nov-03-2014 09:00 AM. Venue: Portalhaus Messe Frankfurt, Strasse der Nationen, 60327 Frankfurt, Germany. Speakers: Ann DeWitt, Senior Director of Investments.

Sanofi-Genzyme BioVentures Presents at 2013 Therapeutic Area Partnerships Conference, Nov-19-2013 09:00 AM

Sanofi-Genzyme BioVentures Presents at 2013 Therapeutic Area Partnerships Conference, Nov-19-2013 09:00 AM. Venue: One Avenue De Lafayette, Boston, MA 02111, United States. Speakers: Bernard Davitian, Vice President of BD Licensing & Structured Investments and Managing Director.

Similar Private Companies By Industry

Company Name Region
Tegrit Retirement Plan Services United States
Guggenheim Securities, LLC United States
Republic Partners, Inc. United States
Corporate Stock Transfer, Inc. United States
ING Institutional Plan Services, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
June 10, 2015
Unum Therapeutics, Inc.
Private Placement
January 30, 2015
Lysosomal Therapeutics Inc.
Private Placement
October 3, 2014
Unum Therapeutics, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sanofi-Genzyme BioVentures, please visit www.genzyme.com/corp/licensing/genzyme_ventures.asp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.